In a recent development, AstraZeneca has acknowledged the potential for rare but serious blood clot side effects associated with their COVID-19 vaccine. This revelation came to light in court documents filed as part of an undisclosed legal case. AstraZeneca collaborated with the University of Oxford to develop the vaccine and is currently involved in legal
British pharmaceutical giant AstraZeneca has acknowledged that its Covid vaccine can lead to a rare blood clotting condition known as Thrombosis with Thrombocytopenia Syndrome (TTS)
AstraZeneca admits rare blood clot risk (TTS) for Covishield vaccine. Expert explains TTS symptoms, causes & who is at risk. While acknowledging the link, doctor assures benefits outweigh risks & urges monitoring for early detection & treatment.